Table 2.
Karl - Pearson correlation | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
High-sensitivity C-reactive protein | Ischemia-modified albumin | Fibrinogen (FIB) | ||||||||||
Type 2 diabetics without hypertension, (DMT2) (n= 35) | Type 2 diabetics with hypertension, (DMT2HTN) (n= 35) | Type 2 diabetics without hypertension, (DMT2) (n= 35) | Type 2 diabetics with hypertension, (DMT2HTN)(n= 35) | Type 2 diabetics without hypertension, (DMT2)(n= 35) | Type 2 diabetics with hypertension, (DMT2HTN)(n= 35) | |||||||
r | p | r | p | r | p | r | p | r | p | r | p | |
TC | 0.457 | 0.005 | 0.788 | <0.001 | 0.658 | <0.001 | 0.967 | <0.001 | 0.379 | 0.005 | 0.389 | <0.001 |
TG | 0.958 | <0.001 | 0.898 | <0.001 | 0.715 | <0.001 | 0.989 | <0.001 | 0.57 | <0.001 | 0.584 | <0.001 |
HDL | -0.874 | <0.001 | -0.133 | 0.445 | -0.837 | <0.001 | -0.107 | 0.047 | -0.654 | <0.001 | -0.611 | 0.033 |
LDL | 0.918 | <0.001 | 0.707 | <0.001 | 0.768 | <0.001 | 0.902 | <0.001 | 0.658 | <0.001 | 0.628 | <0.001 |
HbA1C | 0.937 | <0.001 | 0.742 | <0.001 | 0.661 | <0.001 | 0.912 | <0.001 | 0.588 | <0.001 | 0.548 | <0.001 |
FBS | 0.645 | <0.001 | 0.438 | 0.008 | 0.612 | <0.001 | 0.982 | <0.001 | 0.449 | 0.005 | 0.491 | <0.001 |
SBP | -0.0209 | 0.227 | 0.877 | <0.001 | -0.0443 | 0.008 | -0.453 | 0.007 | -0.18 | 0.303 | -0.18 | 0.004 |
DBP | 0.145 | 0.407 | 0.568 | <0.001 | 0.124 | 0.476 | 0.304 | 0.081 | -0.04 | 0.817 | 0.322 | 0.063 |
BMI | 0.625 | <0.001 | 0.204 | 0.24 | 0.44 | 0.008 | 0.966 | <0.001 | 0.488 | 0.003 | 0.488 | <0.001 |
WHR | 0.85 | <0.001 | 0.496 | 0.002 | 0.794 | <0.001 | 0.99 | <0.001 | 0.599 | <0.001 | 0.579 | <0.001 |
TC, Total cholesterol; TG, Triglycerides; HDL, High-density lipoproteins; LDL, Low-density lipoproteins; HbA1C, Glycated hemoglobin; FBS, Fasting Blood Sugar; SBP, Systolic blood pressure; DBP, Diastolic blood pressure; BMI, Body mass index; WHR, Waist-hip ratio.